These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15498524

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Homocysteine and methionine metabolism in renal failure.
    van Guldener C, Stehouwer CD.
    Semin Vasc Med; 2005 May; 5(2):201-8. PubMed ID: 16047272
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic.
    Lever M, George PM, Dellow WJ, Scott RS, Chambers ST.
    Metabolism; 2005 Jan; 54(1):1-14. PubMed ID: 15562374
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
    Yang SY, Huang JW, Shih KY, Hsu SP, Chu PL, Chu TS, Wu KD.
    Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.
    Perna AF, Acanfora F, Satta E, Lombardi C, Capasso R, Ingrosso D, De Santo NG.
    J Nephrol; 2007 Jan; 20(1):63-5. PubMed ID: 17347975
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes.
    Heinz J, Domröse U, Westphal S, Luley C, Neumann KH, Dierkes J.
    Nephrology (Carlton); 2008 Oct; 13(5):384-9. PubMed ID: 18518942
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V, Kes P, Reiner Z.
    Acta Med Croatica; 2006 Oct; 60(1):21-6. PubMed ID: 16802568
    [Abstract] [Full Text] [Related]

  • 38. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B, Anderstam B, Suliman M, Alvestrand A.
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.